Melanoma cells exhibit, both in vivo and in vitro, intrinsic drug resistanc
e to various chemotherapeutic agents. Cultured human melanoma cells (M14) i
ntrinsically express significant amounts of multidrug resistance-related pr
otein (MRP1) and P-glycoprotein (P-gp) in the Golgi apparatus but do not ex
press these drug transporters on the plasma membrane. A panel of multidrug
resistant (MDR) melanoma cell lines (M14Dx) showing different degrees of re
sistance to doxorubicin (DOX) were isolated. In M14Dx lines, the appearance
of surface P-gp, but not of MRP1 or lung resistance related protein (LRP),
occurred in cells grown in the presence of DOX concentrations higher than
60 nM. Furthermore, P-gp levels appeared to be dose-dependent. Flow cytomet
ry, laser scanning confocal microscopy and cytotoxicity studies demonstrate
d that the activity of the drug extrusion system was related to both surfac
e P-gp expression and resistance to DOX. In conclusion, P-gp, but not MRP1
or LRP, might play a pivotal role in the pharmacologically-induced MDR phen
otype of melanoma cells.